HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology

International Journal of Cancer

Volumn 133, Issue 3, 2013, Pages 637-644

  Lorincz, Attila T ^a   Brentnall, Adam R ^a   Vasiljevic̈, Nataša ^a   Scibior Bentkowska, Dorota ^a   Castanon, Alejandra ^a   Fiander, Alison ^b   Powell, Ned ^b   Tristram, Amanda ^b   Cuzick, Jack ^a   Sasieni, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

biomarkers; cervical cancer; DNA methylation; HPV; triage

Indexed keywords

VIRUS DNA;

ARTICLE; CLASSIFIER; COLPOSCOPY; DNA METHYLATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; OPEN READING FRAME; PREDICTIVE VALUE; PRIORITY JOURNAL; PYROSEQUENCING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS GENOME;

CAPSID PROTEINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; DNA METHYLATION; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INDOLES; MASS SCREENING; NEOPLASM GRADING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84878019181     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28050     Document Type: Article

References (30)

1. Lorincz AT,. The promise and the problems of epigenetics biomarkers in cancer. Expert Opin Med Diagn 2011; 5: 375-9.
2. Robertson KD,. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597-610.
3. Turan T, Kalantari M, Cuschieri K, et al. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 2007; 361: 185-93.
4. Brandsma JL, Sun Y, Lizardi PM, et al. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009; 389: 100-7.
5. Mirabello L, Sun C, Ghosh A, et al. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J Natl Cancer Inst 2012; 104: 1-10.
6. Badal S, Badal V, Calleja-Macias IE, et al. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 2004; 324: 483-92.
7. Franceschi S, Denny L, Irwin KL, et al. Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer 2011; 128: 2765-74.
8. Doeberitz MK, Vinokurova S,. Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections. Arch Med Res 2009; 40: 435-42.
9. Cuzick J, Bergeron C, Doeberitz MK, et al. New technologies and procedures for cervical cancer screening. Vaccine 2012; 30: F107-16.
10. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011; 378: 1868-73.
11. Castle PE, Stoler MH, Wright TC, Jr, et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 2011; 12: 880-90.
12. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
13. Mirabello L, Schiffman M, Ghosh A, et al. Elevated methylation of HPV16 DNA is associated with increased risk of high grade cervical intraepithelial neoplasia. Int J cancer 2013; 132: 1412-22.
14. Kalantari M, Calleja-Macias IE, Tewari D, et al. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 2004; 78: 12762-72.
15. Castanon A, Tristram A, Mesher D, et al. Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial. Br J Cancer 2012; 106: 45-52.
16. McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 2006; 100: 229-35.
17. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
18. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-5.
19. Cricca M, Morselli-Labate AM, Venturoli S, et al. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 2007; 106: 549-57.
20. Vasiljevic N, Wu K, Brentnall AR, et al. Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Dis Markers 2011; 30: 151-61.
21. McCullagh P, Nelder JA,. Generalized linear models, 2nd ed. London: Chapman and Hall/CRC, 1989.
22. Davidson AC, Hinkley DV,. Bootstrap methods and their applications. Cambridge: Cambridge University Press, 1997.
23. Agresti A, Coull BA,. Approximate is better than «exact» for interval estimation of binomial proportions. Am Statist 1998; 52: 119-26.
24. Wentzensen N, Sun C, Ghosh A, et al. Methylation of HPV18, HPV31, and HPV45 genomes is associated with cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst 2012; 104: 1738-49.
25. Overmeer RM, Louwers JA, Meijer CJ, et al. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Int J Cancer 2010; 129: 2218-25.
26. Hesselink AT, Heideman DA, Steenbergen RD, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res 2011; 17: 2459-65.
27. Quillien V, Lavenu A, Karayan-Tapon L, et al. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients. Cancer 2012; 118: 4201-11.
28. Clarke J, Wu HC, Jayasinghe L, et al. Continuous base identification for single-molecule nanopore DNA sequencing. Nat Nanotechnol 2009; 4: 265-70.
29. Wojdacz TK,. Methylation-sensitive high-resolution melting in the context of legislative requirements for validation of analytical procedures for diagnostic applications. Expert Rev Mol Diagn 2012; 12: 39-47.
30. Wilting SM, van Boerdonk RA, Henken FE, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 2010; 9: 167.